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Summary We report a case of acute hepatitis A in a 30-year-old pregnant woman with hepatitis
onset occurring at time of delivery. Both neonate and her mother were isolated from other
patients. The hepatitis A virus (HAV) genotype was Ia. Total anti-HAVantibodies and HAV RNAwere
not detected from the newborn in a serum collected the first day of life; neither clinical symptoms
nor increased ALT levels were observed during the six first days of life. The mother quickly and
fully recovered. Hepatitis A has been scarcely reported during pregnancy; four cases, to our
knowledge, have been previously described close to delivery. HAV vertical transmission seems to
be very rare. No severe outcome has been described in mothers and newborns. Nevertheless, HAV
infection might represent a concern in pregnant women in industrialized countries in view of its
mortality rate among susceptible adults and its potential involvement in nosocomial outbreaks.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Hepatitis A virus (HAV) infection is a common cause of acute
hepatitis worldwide that can be prevented by safe and
effective vaccines.1,2 Although typically self-limited, it is
potentially life-threatening, with an estimated fatality rate
of 0.3—0.6% reaching 1.8% among adults older than 50
years.3,4 In industrialized countries, the proportion of sus-
ceptible adults has increased with improvements in public
health sanitation, as demonstrated by falling HAV seropre-
valence rates.2* Corresponding author. Tel.: +33 (0) 4 91 38 79 69;
fax: +33 (0) 4 91 38 55 18.
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1201-9712/$36.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.06.009Contrasting with the large body of data about acute
hepatitis A worldwide, its occurrence during pregnancy has
been scarcely reported. We report herein a case of acute HAV
infection in a pregnant woman with hepatitis onset occurring
at time of delivery.
Case report
A 30-year-old woman was admitted to our institution in
February 2007 in gestational week 39 for external cephalic
version due to breech presentation. The patient presented a
cough without fever. Hepatomegaly was also noted. Systema-
tic physical and biological exams performed five days before
admittance, following mild uterine contractions and bron-
chial subfebrile syndrome, did not reveal any anomaly exceptPublished by Elsevier Ltd. All rights reserved.
e50 A. Motte et al.an elevated alkaline phosphatase level of 278 UI/l (normal
values<130 IU/l). Alanine aminotransferase (ALT) and aspar-
tate aminotransferase (AST) levels were within normal
ranges (<30 IU/l). At admission, ALT and AST levels had
dramatically increased to 1959 IU/l and 918 IU/l, respec-
tively. Bilirubinemia was 37 mmol/l (normal values
<17 mmol/l) and the prothrombin index was 63% (normal
values >80%). Abdominal ultrasonography was normal.
HAV infection was promptly diagnosed the same day as
admission through the detection of IgM anti-HAVantibodies in
serum using the Axsym Abbott assay (Abbott Diagnostics,
Wiesbaden, Germany). The diagnosis was then confirmed
using in-house molecular assays to detect HAV RNA in serum.
HAV RNA was first detected by a real-time one-step RT-PCR
assay targeting the VP1 non-structural coding region of the
HAV genome using a Stratagene Mx3000P instrument with
Superscript III platinum one-step qRT-PCR (Invitrogen Life
Technologies, Carlsbad, CA). Sequences of primers and probe
are as follows: HavMrsRTfwd: 50 ggtaggctacgggtgaaac, 393 nt
(location was defined in reference to GenBank accession no.
M14707); HavMrsRTRev: 50 gcggatattggtgagttgtt, 462 nt;
HavMrsPr: FAM-cttargctartacttctatgaagagatgc-TAMRA, 413
nt. The HAV genome sequence was obtained by RT-PCR using
Superscript II polymerase (Invitrogen Life Technologies) with
primers HavMrsFwd1 (50 tgctcctctttatcatgctat, 2170 nt) and
HavMrsRev1 (50 aagttttcctggagaggtgtga, 3284 nt), with a
second round of PCR using Roche Taq polymerase (Roche
Diagnostics, Mannheim, Germany) with primers HavMrsFwd1
and HavMrs2Rev2 (50 catatagaatgcaggaagcca, 3111 nt). The
PCR fragments were purified and then directly sequenced
using Big Dye Terminator cycle sequencing kit version 1.1 on
the ABI Prism 3130 genetic analyzer with primers
HavMrsFwd1, HavMrs2Rev2, HavMrsS1 (50 gtctcatttcttgtg-
cacttt, 2480 nt) and HavMrsS2 (50 aatttgcaatctgaatagaaacc,
2891 nt) (Applied Biosystems, Branchburg, NJ) to obtain a
fragment of nearly 900 bp. The HAV genotype, determined
using phylogenetic analysis, was Ia.
Markers for hepatitis B, C and E viruses, Epstein—Barr
virus, cytomegalovirus and toxoplasmosis were negative or
showed past immunization. The patient did not report recent
travel, contact with travellers or shellfish consumption.
There was no transfusion history. Prior exposure to household
members with acute hepatitis A was not identified.
Because of hepatocellular insufficiency, transverse pre-
sentation and anamnios, elective caesarian section was per-
formed in emergency. At birth, physical examination of the
newborn was normal. The Apgar score was 10/10. Both
neonate and her mother were isolated from other patients
in the clinical unit. Neither clinical symptoms nor increased
ALT levels were observed for the neonate. Total anti-HAV
antibodies (Axsym Abbott) and HAV RNAwere not detected in
serum collected the first day of life. The mother quickly and
fully recovered, and left hospital at day 6 post delivery. No
follow-up was possible because the mother and her child did
not attend subsequent consultations. However, telephone
interview did not reveal any symptoms in either individual
during the two months following birth.
Discussion
Data on the incidence and outcome of hepatitis A during
pregnancy are scant. In large retrospective case seriesreported in Ireland and India, the incidence of HAV infection
during pregnancy was found to be very low, accounting for
<2% of hepatitis cases.5 To our knowledge, four cases have
been previously diagnosed close to delivery, between two
weeks before and two weeks after delivery, and none at time
of delivery.
However, HAV seroprevalence has substantially declined
in the last decades in industrialized countries because of
improved sanitation.2,6 Hence, in these geographical
areas, a growing proportion of adults, including pregnant
women, are susceptible to HAV infection. This might be a
concern in view of the potential severity of adulthood
hepatitis A.4
It is commonly acknowledged that hepatitis A is not
associated with a severe outcome or complications during
pregnancy,1 as observed in our patient. By contrast, Elinav
et al.5 recently reported that 69% of pregnant women with
acute hepatitis A infection during the second and third
trimesters of pregnancy have gestational complications,
including premature contractions, placental separation and
premature rupture of membranes, which lead to preterm
labor. However, in this case study, the outcome for the child
was favorable.
Mother-to-child HAV transmission seems to be very rare.
Four cases of intrauterine infection have been reported. In
two of these cases, HAV infection was associated with fetal
ascitis, meconium peritonitis and perforation of the distal
ileum, necessitating post-natal surgery, but the newborns
subsequently recovered. Both infections occurred after
maternal symptomatic hepatitis A at 20 and 13 weeks of
gestation.7,8 The two other cases of intrauterine transmission
occurred following maternal icteric hepatitis A 20 days
before delivery, resulting in neonatal icteric hepatitis A on
the third day of life with subsequent full recovery.9 HAV
mother-to-child transmission following hepatitis onset in
the mother later than gestational week 33 have been also
reported in four cases, and might be attributed to contact
with blood or feces.10—13 Jaundice was noticed in three
mothers 10—12, and mild neonatal acute hepatitis occured
in three cases. 10—13. In our case, HAV RNAwas negative in the
neonate on the first day of life and no jaundice occurred
during the first six days of life, but unfortunately the child
could not be tested thereafter.
A potential concern arising from acute hepatitis A in
pregnant women and neonates is the risk of transmission of
HAV to other infants, mothers or medical workers. Thus,
outbreaks in neonatal intensive care units have been pre-
viously described and subsequently ascribed to a case of
vertical HAV transmission.10,14 To prevent such nosocomial
transmission, the infected mother and the neonate should
be isolated, and careful hygiene practices emphasized.4,6
In summary, acute HAV infection seems to be rare during
pregnancy, especially at time of delivery. No severe out-
come has been described in mothers and newborns. Never-
theless, this vaccine-preventable infection represents a
concern in the setting of pregnancy in industrialized coun-
tries in view of its mortality rate among susceptible adults
and the potential involvement of HAV in nosocomial
outbreaks.
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